Tadalafil:the preference of erectile dysfunction patients and their partners
Wen-Jun Bai
Abstract
Wen-Jun Bai
Abstract
Erectile Dysfunction(ED)is a common male diseases which directly affects the life quality of the patients and their partners.Phosphodiesterase 5(PDE5)inhibitors are the first choice among the drugs for the treatment of ED.Nowadays,3 types of PDE5 inhibitors(Sildenafil,vardenafil and tadalafil)are commonly used in clinic at practice.But which is preferred by ED patients and their partners and what are the potential reasons for their preference?
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Erectile Dysfunction(ED)is a common male diseases which directly affects the life quality of the patients and their partners.Phosphodiesterase 5(PDE5)inhibitors are the first choice among the drugs for the treatment of ED.Nowadays,3 types of PDE5 inhibitors(Sildenafil,vardenafil and tadalafil)are commonly used in clinic at practice.But which is preferred by ED patients and their partners and what are the potential reasons for their preference?
Key concepts: Vardenafil, Tadalafil, Erectile dysfunction, Sildenafil, Medicine, Preference, Quality of life (healthcare), cGMP-specific phosphodiesterase type 5